KRAS and neoplasm: It is possible that a subset of samples could have KRAS mutations not picked up by ctDNA analysis due to lower tumor shedding, as measured by circulating tumor fraction (CTF), the percentage of cell-free DNA that is derived from tumor cells in a blood sample.